Otuyeli Ekundayo, PhD student

Otuyeli Ekundayo PhD student

What were the most interesting concepts raised during the symposium?

The primary concept I really took was that bipolar disorder is being seen more as a spectrum, instead of an all-or-none concept. As Dr Ian Hickie explained, basically all those risk factors are there. What has been difficult is determining when those risk factors become a clinical entity which requires intervention. Take, for instance, agitation, irritability, anxiety; we all have them, so the question is, when does it become too much? When does it become difficult?

I think that’s been the problem with diagnosis so far; we’ve been looking for an entity that doesn’t actually really exist but is more a spectrum flowing from one condition into another. Now we’re not looking for people with bipolar disorder per se, we’re looking for people at risk for bipolar disorder; we can catch it early.

How do you see the new MINI diagnostic tool module being incorporated into your daily practice?

I was particularly impressed with the MINI because Dr Young was explaining that the previous models were fixed. So you just put some people in a box as depressive, some people in a box as manic and then some people in a box as mixed. The truth is that they all flow into each other. It’s better to think of it this way, assume people are just manic-depressive but then, if you identify indicators like irritability, agitation, anxiety you now have the MINI questionnaire to help confirm whether a person with bipolar I disorder fits into a mixed state… there’s still going to be lots of individualisation, there’s still going to be doctor-patient assessment and essentially this guideline just helps to remind people that the mixed state exists and we should pay a bit more attention to it.

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country